Revelation Biosciences Inc REVB

$4.26 -0.12 (-2.63%)

Valuation

Market cap
2,993,000
Revenue TTM
$0
Net income TTM
$-8,910,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
6,500
Avg volume
13,912
Day's range
$4.17 – $4.50
Shares out
683,000
Stochastic %K
63%
Beta
-0.13
Analysts
Strong Buy
Price target
$76.23

Price

Company profile

Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a proprietary formulation platform of phosphorylated hexaacyl disaccharide (PHAD), an established Toll-like receptor 4 (TLR) agonist that works by modulating and rebalancing a dysregulated inflammatory res...

Show more

Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a proprietary formulation platform of phosphorylated hexaacyl disaccharide (PHAD), an established Toll-like receptor 4 (TLR) agonist that works by modulating and rebalancing a dysregulated inflammatory response. It also engages in the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed its name to Revelation Biosciences, Inc. in January 2022. Revelation Biosciences, Inc. was incorporated in 2019 and is based in San Diego, California.

Industry
Biotechnology
Sector
Healthcare
Phone
650 800 3717
Website
https://www.revbiosciences.com
Address
4660 La Jolla Village Drive, Suite 100, San Diego, United States

Latest news

Stocktwits

ReversalRuler Nov 13, 7:13 PM
If you’ve ever wanted to catch a short squeeze early instead of watching it rip after the fact, this group is built for that. Sharing momentum, setups, and what we’re watching as it develops, not when it’s already gone. Click link and join for Free ⭐ $POM $EHGO $REVB $MBRX ..
0 replies
ZacksSCR Nov 6, 5:05 PM
$REVB Moving Toward Commercialization https://scr.zacks.com/news/news-details/2026/REVB-Approaching-Important-Period-in-Great-Shape/default.aspx
0 replies
d_risk Nov 6, 12:15 AM
$REVB - REVELATION BIOSCIENCES, INC. - 10Q - Updated Risk Factors Revelation disclosed that Nasdaq would start counting compliance days under its $5 million listing-value rule on the first business day after the SEC stay ends. The company said its listed securities were below that threshold. #Biotechnology #StockMarketListing #NasdaqCompliance #MarketVolatility #DelistingRisk 🟢 Added 🟠 Removed https://d-risk.ai/REVB/10-Q/2026-11-05
0 replies
focafoca99 Nov 5, 10:42 PM
$REVB released its Q3 and nine-month 2026 results via a press release.
0 replies
Day3 Oct 29, 11:24 AM
$REVB Strong watch today as a recent R/S low float sympathy play, assuming $NUWE goes bananas. 570k float and no ATMs/equity lines to dilute from.
0 replies
CyrusTrade Oct 23, 3:42 PM
$REVB the only right option is to distribute the remaining cash among shareholders and close the shop. The only problem is that shareholder value is inversely proportional to management’s interests.
1 replies
ErockTrades Oct 23, 2:32 AM
$REVB This might get silly tomorrow if it goes over 4.20
1 replies
CyrusTrade Oct 21, 2:14 PM
$REVB will need another RS in 3 months
1 replies